Related references
Note: Only part of the references are listed.Bile acid metabolism and FXR-mediated effects in human cholestatic liver disorders
Antonio Molinaro et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2022)
MicroRNA-193b impairs muscle growth in mouse models of type 2 diabetes by targeting the PDK1/Akt signalling pathway
Shu Yang et al.
DIABETOLOGIA (2022)
KLF10 promotes nonalcoholic steatohepatitis progression through transcriptional activation of zDHHC7
Shu Yang et al.
EMBO REPORTS (2022)
Molecular Basis of Bile Acid-FXR-FGF15/19 Signaling Axis
Takeshi Katafuchi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
MOLECULAR PHYSIOLOGY OF BILE ACID SIGNALING IN HEALTH, DISEASE, AND AGING
Alessia Perino et al.
PHYSIOLOGICAL REVIEWS (2021)
HERB: a high-throughput experiment- and reference-guided database of traditional Chinese medicine
ShuangSang Fang et al.
NUCLEIC ACIDS RESEARCH (2021)
Tectorigenin alleviates intrahepatic cholestasis by inhibiting hepatic inflammation and bile accumulation via activation of PPARγ
Jiaqing Xiang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Pterostilbene Alleviates Cholestasis by Promoting SIRT1 Activity in Hepatocytes and Macrophages
Chuanrui Ma et al.
FRONTIERS IN PHARMACOLOGY (2021)
Whole blood transcriptomic investigation identifies long non-coding RNAs as regulators in sepsis
Lixin Cheng et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Developments in bile salt based therapies: A critical overview
Joanne M. Donkers et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Dihydropyrazole Derivatives Containing Benzo Oxygen Heterocycle and Sulfonamide Moieties Selectively and Potently Inhibit COX-2: Design, Synthesis, and Anti-Colon Cancer Activity Evaluation
Xiao-Qiang Yan et al.
MOLECULES (2019)
Macrophage-derived IL-1β/NF-κB signaling mediates parenteral nutrition-associated cholestasis
Karim C. El Kasmi et al.
NATURE COMMUNICATIONS (2018)
The gut-adherent microbiota of PSC-IBD is distinct to that of IBD
Mohammed Nabil Quraishi et al.
GUT (2017)
Analyzing the hepatoprotective effect of the Swertia cincta Burkillextract against ANIT-induced cholestasis in rats by modulating the expression of transporters and metabolic enzymes
Lili Xu et al.
JOURNAL OF ETHNOPHARMACOLOGY (2017)
Management of cholestatic disease in 2017
Elsemieke de Vries et al.
LIVER INTERNATIONAL (2017)
Paeoniflorin attenuates ANIT-induced cholestasis by inhibiting apoptosis in vivo via mitochondria-dependent pathway
Hou-Qin Zhou et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Sweroside ameliorates α-naphthylisothiocyanate-induced cholestatic liver injury in mice by regulating bile acids and suppressing pro-inflammatory responses
Qiao-ling Yang et al.
ACTA PHARMACOLOGICA SINICA (2016)
Oleanolic acid attenuates obstructive cholestasis in bile duct-ligated mice, possibly via activation of NRF2-MRPs and FXR antagonism
Pan Chen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Characterization of animal models for primary sclerosing cholangitis (PSC)
Peter Fickert et al.
JOURNAL OF HEPATOLOGY (2014)
Discovery of 4,6-substituted-(diaphenylamino)quinazolines as potent c-Src inhibitors
Jing-Ran Li et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2013)
Bile Acid Metabolism and Signaling
John Y. L. Chiang
COMPREHENSIVE PHYSIOLOGY (2013)
Farnesoid X Receptor Deficiency Improves Glucose Homeostasis in Mouse Models of Obesity
Janne Prawitt et al.
DIABETES (2011)
Lowering Bile Acid Pool Size with a Synthetic Farnesoid X Receptor (FXR) Agonist Induces Obesity and Diabetes through Reduced Energy Expenditure
Mitsuhiro Watanabe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
FXR, a multipurpose nuclear receptor
Florence Y. Lee et al.
TRENDS IN BIOCHEMICAL SCIENCES (2006)
Abnormal intestinal permeability in primary biliary cirrhosis
Jordan J. Feld et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
Benefit of farnesoid X receptor inhibition in obstructive cholestasis
Catherine Stedman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice
YQ Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Regulation of ileal bile acid-binding protein expression in Caco-2 cells by ursodeoxycholic acid: Role of the farnesoid X receptor
G Campana et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Ecdysone-controlled expression of transgenes
LD Graham
EXPERT OPINION ON BIOLOGICAL THERAPY (2002)
Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis
CJ Sinal et al.
CELL (2000)
Share Paper
